Momelotinib's Spleen, Symptom and Anemia Efficacy Is Maintained in Intermediate/High Risk Myelofibrosis Patients with Thrombocytopenia
暂无分享，去创建一个
S. Verstovsek | R. Donahue | R. Mesa | A. Vannucchi | Sung-Soo Yoon | Á. Illés | N. Tzvetkov | U. Platzbecker | Z. Nagy | W. Prejzner | J. Mayer | J. Kiladjian | B. Klencke | N. Bubnoff | S. Grosicki | Y. Goh | I. Kirgner | M. Lazaroiu | T. Woźny | Åsa Rangert Derolf